Literature DB >> 7829768

Lithium response and genetics of affective disorders.

P Grof1, M Alda, E Grof, P Zvolsky, M Walsh.   

Abstract

The authors have carried out an investigation of psychiatric morbidity in families of patients who responded and failed to respond to long-term lithium treatment. The study included 121 probands with RDC primary affective disorders and 903 first-degree relatives and spouses. Seventy-one probands were responders and 50 were nonresponders to long-term lithium treatment. Extended to 20 years, the follow-up of patients and their families provided substantial information relevant for the diagnosis and reliable assessment of lithium response. The diagnoses were based on all available information, SADS-L interviews and RDC criteria. The principal statistical methods were survival analysis and Cox regression analysis. The results revealed a significantly higher frequency of bipolar disorder in the relatives of lithium responders (3.8% vs. 0%). Schizophrenia was more common in the families of nonresponders (2.4% vs. 0.3%). There were no significant differences in the rates of other psychiatric disorders. Both family history and the proband's diagnosis contribute independently to predicting response to long-term lithium.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7829768     DOI: 10.1016/0165-0327(94)90066-3

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  32 in total

Review 1.  The bipolar spectrum--the shaping of a new paradigm in psychiatry.

Authors:  Hagop S Akiskal
Journal:  Curr Psychiatry Rep       Date:  2002-02       Impact factor: 5.285

2.  Association and linkage studies of candidate genes involved in GABAergic neurotransmission in lithium-responsive bipolar disorder.

Authors:  A Duffy; G Turecki; P Grof; P Cavazzoni; E Grof; R Joober; B Ahrens; A Berghöfer; B Müller-Oerlinghausen; M Dvoráková; E Libigerová; M Vojtĕchovský; P Zvolský; A Nilsson; R W Licht; N A Rasmussen; M Schou; P Vestergaard; A Holzinger; C Schumann; K Thau; C Robertson; G A Rouleau; M Alda
Journal:  J Psychiatry Neurosci       Date:  2000-09       Impact factor: 6.186

Review 3.  Toward a comprehensive clinical staging model for bipolar disorder: integrating the evidence.

Authors:  Anne Duffy
Journal:  Can J Psychiatry       Date:  2014-12       Impact factor: 4.356

4.  The pharmacogenetics of lithium response depends upon clinical co-morbidity.

Authors:  Troy Bremer; Cornelius Diamond; Rebecca McKinney; Tatyana Shehktman; Thomas B Barrett; Chris Herold; John R Kelsoe
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

5.  Predictors of lithium response in bipolar disorder.

Authors:  Sarah K Tighe; Pamela B Mahon; James B Potash
Journal:  Ther Adv Chronic Dis       Date:  2011-05       Impact factor: 5.091

6.  Pharmacogenomic predictors of citalopram treatment outcome in major depressive disorder.

Authors:  Firoza Mamdani; Marcelo T Berlim; Marie-Martine Beaulieu; Gustavo Turecki
Journal:  World J Biol Psychiatry       Date:  2013-03-26       Impact factor: 4.132

7.  A genomewide association study of response to lithium for prevention of recurrence in bipolar disorder.

Authors:  Roy H Perlis; Jordan W Smoller; Manuel A R Ferreira; Andrew McQuillin; Nick Bass; Jacob Lawrence; Gary S Sachs; Vishwajit Nimgaonkar; Edward M Scolnick; Hugh Gurling; Pamela Sklar; Shaun Purcell
Journal:  Am J Psychiatry       Date:  2009-05-15       Impact factor: 18.112

8.  Pharmacogenomics of mood stabilizers in the treatment of bipolar disorder.

Authors:  Alessio Squassina; Mirko Manchia; Maria Del Zompo
Journal:  Hum Genomics Proteomics       Date:  2010-08-03

9.  BDNF protein levels are decreased in transformed lymphoblasts from lithium-responsive patients with bipolar disorder.

Authors:  Michael Tseng; Martin Alda; Li Xu; Xiujun Sun; Jun-Feng Wang; Paul Grof; Gustavo Turecki; Guy Rouleau; L Trevor Young
Journal:  J Psychiatry Neurosci       Date:  2008-09       Impact factor: 6.186

10.  Lithium: a key to the genetics of bipolar disorder.

Authors:  Cristiana Cruceanu; Martin Alda; Gustavo Turecki
Journal:  Genome Med       Date:  2009-08-19       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.